Novavax, Inc. (NVAX)
8.98
-0.29
(-3.13%)
USD |
NASDAQ |
May 21, 16:00
9.01
+0.03
(+0.33%)
After-Hours: 19:59
Novavax Research and Development Expense (TTM) : 345.26M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Moderna, Inc. | 2.69B |
| Merck & Co., Inc. | 21.57B |
| Pfizer Inc. | 10.52B |
| AbbVie, Inc. | 9.501B |
| Intellia Therapeutics, Inc. | 351.67M |